Telepharmacy Robotic Medicine Delivery Unit "TRMDU" Assessment
| Status: | Completed |
|---|---|
| Conditions: | Chronic Pain, Hospital, Neurology, Psychiatric |
| Therapuetic Areas: | Musculoskeletal, Neurology, Psychiatry / Psychology, Other |
| Healthy: | No |
| Age Range: | 18 - Any |
| Updated: | 4/2/2016 |
| Start Date: | March 2010 |
| End Date: | June 2011 |
| Contact: | Daniel R Touchette, Pharm.D., MA |
| Email: | drtouche@uic.edu |
| Phone: | 3123553204 |
Evaluation of a Telepharmacy Robotic Medicine Delivery Unit in Warrior Transition Unit Patients With Traumatic Brain Injury, Post-Traumatic Stress Disorder, or Polytrauma
The objective of this study is to evaluate whether use of TRMDU in addition to medication
review leads to improved outcomes and reduced health care costs for patients when compared
with medication review alone. The study will be conducted in patients assigned to Department
of Defense (DOD) Warrior Transition Units (WTU's), similar DOD units, and VA polytrauma
centers.
review leads to improved outcomes and reduced health care costs for patients when compared
with medication review alone. The study will be conducted in patients assigned to Department
of Defense (DOD) Warrior Transition Units (WTU's), similar DOD units, and VA polytrauma
centers.
The military has been witnessing an increased number of patients with combat related
impairments such as traumatic brain injury, post traumatic stress disorder and polytrauma
which has lead to sub optimal medication self management. TRMDU is a medical device
developed by INRange Systems Inc. that delivers medications and emits a sound alert to
assist the patient. It can be used in a hospital, clinic, or residential setting. It can be
remotely accessed by the health care professionals, and it allows physicians and other
prescribers to remotely change scheduling or adjust prescriptions.
Use of TRMDU in hospital settings is expected to improve outcomes by improving medication
self management, increasing adherence, reducing medication errors, and thereby associated
costs. Further, it may contribute to overall improvement in a patient's psychological
well-being and quality of life.
impairments such as traumatic brain injury, post traumatic stress disorder and polytrauma
which has lead to sub optimal medication self management. TRMDU is a medical device
developed by INRange Systems Inc. that delivers medications and emits a sound alert to
assist the patient. It can be used in a hospital, clinic, or residential setting. It can be
remotely accessed by the health care professionals, and it allows physicians and other
prescribers to remotely change scheduling or adjust prescriptions.
Use of TRMDU in hospital settings is expected to improve outcomes by improving medication
self management, increasing adherence, reducing medication errors, and thereby associated
costs. Further, it may contribute to overall improvement in a patient's psychological
well-being and quality of life.
Inclusion Criteria: Subjects must be
- At least 18 years of age
- Alert and oriented to person , place and time
- Primarily use English language for written and oral communication
- Have diagnosis of Traumatic Brain Injury(TBI) Multiple Traumatic Brain Injury (MTBI),
Post Traumatic Stress Disorder (PTSD) or Polytrauma.
- Taking at least 4 chronic prescription medications
- Living in a participating WTU or enrolled in Tampa Veterans Administration polytrauma
outpatient treatment facility at the time of enrollment
- Achieve a minimum score of 24 on Mini-Mental State Examination
Exclusion Criteria: If patients meet following criteria they are excluded from the study
- Disabilities preventing safe use of the TRMDU
- Projected life expectancy of less than 3 months
We found this trial at
3
sites
Click here to add this to my saved trials
Click here to add this to my saved trials
Click here to add this to my saved trials